MFG
BSX icon

MidWestOne Financial Group’s Boston Scientific BSX Stock Holding History

MidWestOne Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.98M Buy
20,718
+3,230
+18% +$317K 0.22% 95
2025
Q3 		$1.71M Buy
17,488
+2,394
+16% +$248K 0.21% 106
2025
Q2 		$1.62M Sell
15,094
-506
-3% -$51.2K 0.21% 111
2025
Q1 		$1.57M Buy
15,600
+677
+5% +$68.2K 0.22% 103
2024
Q4 		$1.33M Sell
14,923
-789
-5% -$69.5K 0.19% 114
2024
Q3 		$1.32M Sell
15,712
-934
-6% -$73.6K 0.18% 119
2024
Q2 		$1.28M Sell
16,646
-619
-4% -$45.3K 0.23% 114
2024
Q1 		$1.18M Buy
17,265
+168
+1% +$10.8K 0.21% 127
2023
Q4 		$988K Buy
17,097
+90
+0.5% +$4.8K 0.19% 135
2023
Q3 		$898K Buy
17,007
+1,882
+12% +$98.7K 0.2% 128
2023
Q2 		$818K Buy
15,125
+2,249
+17% +$117K 0.18% 146
2023
Q1 		$644K Buy
12,876
+797
+7% +$37.6K 0.15% 165
2022
Q4 		$559K Buy
12,079
+4,813
+66% +$208K 0.12% 171
2022
Q3 		$281K Sell
7,266
-183
-2% -$7.34K 0.07% 197
2022
Q2 		$278K Sell
7,449
-621
-8% -$25.3K 0.07% 196
2022
Q1 		$357K Sell
8,070
-372
-4% -$16.1K 0.08% 197
2021
Q4 		$359K Buy
8,442
+127
+2% +$5.34K 0.08% 195
2021
Q3 		$361K Sell
8,315
-387
-4% -$17.1K 0.08% 182
2021
Q2 		$372K Sell
8,702
-12,104
-58% -$509K 0.09% 176
2021
Q1 		$804K Sell
20,806
-4,213
-17% -$159K 0.19% 116
2020
Q4 		$899K Buy
25,019
+9,446
+61% +$340K 0.25% 102
2020
Q3 		$595K Sell
15,573
-2,638
-14% -$102K 0.2% 128
2020
Q2 		$639K Buy
18,211
+8,955
+97% +$322K 0.27% 73
2020
Q1 		$302K Buy
9,256
+333
+4% +$13K 0.11% 151
2019
Q4 		$403K Sell
8,923
-291
-3% -$12.2K 0.08% 171
2019
Q3 		$375K Sell
9,214
-1,105
-11% -$46.8K 0.12% 162
2019
Q2 		$444K Buy
+10,319
New +$397K 0.12% 175

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

MidWestOne Financial Group's BSX Position: Q4 2025 in Review

MidWestOne Financial Group increased its Boston Scientific (BSX) stake by 18% in Q4 2025, buying an estimated $317K and bringing the position to 20,718 shares worth $1.98M. The position accounts for 0.22% of the portfolio, ranked #95.

MidWestOne Financial Group first reported a position in BSX in Q2 2019 and has held it in 27 quarters since. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

  • MidWestOne Financial Group held 20,718 shares of Boston Scientific worth $1.98M as of Q4 2025.
  • MidWestOne Financial Group bought 3,230 Boston Scientific shares in Q4 2025, an estimated $317K.
  • Boston Scientific made up 0.22% of MidWestOne Financial Group's portfolio in Q4 2025, its #95 holding.
  • MidWestOne Financial Group first reported a position in Boston Scientific in Q2 2019 and has held it in 27 quarters since.
  • 1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.